02
Dec
Justicia Shipena The cost of a new twice-a-year HIV prevention and treatment injection, Lenacapavir, is too high for immediate rollout in Namibia’s public health system. Health minister Dr Esperance Luvindao announced this during the World AIDS Day commemoration in Otjiwarongo on Monday, saying the long-acting injectable has the potential to change HIV treatment but remains out of reach for most public patients. She said the ministry has begun the regulatory approval process so that people who can afford the medication in the private sector may access it sooner. “Our ultimate goal is equity. No one should be denied the future…
